Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary

Glaukos

29/07/2026 23:33

Glaukos Corp GKOS.N reported a quarterly adjusted loss of 14 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -24 cents.  The mean expectation of fifteen analysts for the quarter was for a loss of 21 cents per share. Wall Street expected results to range from -31 cents to -6 cents per share.
Revenue rose 49.5% to $185.61 million from a year ago; analysts expected $150.92 million. 
Glaukos Corp's reported EPS for the quarter was a loss of 31 cents​.
The company reported a quarterly loss of $18.38 million.
Glaukos Corp shares had risen by 8.3% this quarter and gained 34.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 1.1% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," 1 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for Glaukos Corp is $166.50, about 2.9% above its last closing price of $161.66
This summary was machine generated from LSEG data July 29 at 10:33 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.21
-0.14
Beat
Mar. 31 2026 
-0.27
-0.18
Beat
Dec. 31 2025 
-0.20
-0.28
Missed
Sep. 30 2025 
-0.26
-0.16
Beat